small molecule

ZEMURON

ROCURONIUM BROMIDE

Loss of exclusivity—loss of exclusivity

CompanyOrganon →See this company's full patent-cliff portfolio

Drug detail

Brand name	ZEMURON
Active ingredient	ROCURONIUM BROMIDE
Strength	100MG/10ML (10MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons
Dosage form	INJECTABLE
Route	INJECTION
Modality	Small molecule
FDA approval	March 1994
Marketing status	DISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.